Ocular Toxoplasmosis: Diagnosis, When to Treat and Regimens
Last updated: October 2026
Key points in 60 seconds
Commonest cause of infectious posterior uveitis: "headlight in the fog" lesion beside a pigmented scar.
Diagnosis is mainly clinical; positive IgG supports it, PCR helps in atypical cases.
Treat lesions threatening the macula or disc, large lesions, severe vitritis and immunocompromised patients.
Regimens include trimethoprim-sulfamethoxazole or pyrimethamine-based therapy, with oral steroid after antimicrobial cover.
Toxoplasmosis is the commonest cause of infectious posterior uveitis worldwide. Most cases are recurrences at the edge of an old scar, and the key decisions are whether to treat and which regimen to use.
Recognising it
Typical lesion: a fluffy white focal retinochoroiditis beside a pigmented scar, with overlying vitritis: the "headlight in the fog".
Often unilateral, with floaters and blurred vision; anterior uveitis and raised IOP can occur.
Atypical forms: punctate outer retinal toxoplasmosis, large or multifocal lesions in the elderly and immunocompromised, neuroretinitis, and retinal vasculitis (Kyrieleis plaques).
Congenital toxoplasmosis: bilateral macular scars, with hydrocephalus and intracranial calcification in severe cases.
Diagnosis
Mainly clinical. Positive IgG serology supports it (a negative result makes it unlikely); IgM suggests recent infection.
In atypical cases, PCR of aqueous or vitreous for Toxoplasma DNA, or the Goldmann–Witmer coefficient, confirms the diagnosis.
Test for HIV in atypical, extensive or bilateral disease.
When to treat
Lesions within the vascular arcades or near the disc or fovea, large lesions (over one disc diameter), marked vitritis, reduced vision, immunocompromise, pregnancy and neonates.
Small peripheral lesions in immunocompetent adults are self-limiting and may be observed.
Regimens (adults)
Regimen
Dose
Notes
Classic triple therapy
Pyrimethamine 100 mg loading, then 25–50 mg daily; sulfadiazine 1 g four times daily; folinic acid 15 mg (daily or three times weekly)
Kim SJ et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology 2013;120:371–8
Soheilian M et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 2005;112:1876–82
Felix JP et al. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis. Am J Ophthalmol 2014;157:762–6
Patel D. Ocular Toxoplasmosis: Diagnosis, When to Treat and Regimens. RPC Rounds (Sadbhaav Eye Clinic). Updated October 2026. Available at: https://www.sadbhaavclinic.com/ocular-toxoplasmosis.html. Accessed [date].
Written and medically reviewed by Dr. Dhaval Patel, MD (Ophthalmology, AIIMS New Delhi) · Editorial policy